annual ROE:
-32.02%+18.14%(+36.16%)Summary
- As of today (June 29, 2025), CRNX annual return on equity is -32.02%, with the most recent change of +18.14% (+36.16%) on December 31, 2024.
- During the last 3 years, CRNX annual ROE has risen by +10.96% (+25.50%).
- CRNX annual ROE is now -133.00% below its all-time high of 97.02%, reached on December 31, 2016.
Performance
CRNX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-32.07%+1.82%(+5.37%)Summary
- As of today (June 29, 2025), CRNX quarterly return on equity is -32.07%, with the most recent change of +1.82% (+5.37%) on March 31, 2025.
- Over the past year, CRNX quarterly ROE has increased by +15.09% (+32.00%).
- CRNX quarterly ROE is now -140.37% below its all-time high of 79.44%, reached on June 30, 2018.
Performance
CRNX quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CRNX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +36.2% | +32.0% |
| 3 y3 years | +25.5% | +30.8% |
| 5 y5 years | +25.6% | +29.1% |
CRNX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +36.7% | at high | +44.6% |
| 5 y | 5-year | at high | +36.7% | at high | +44.6% |
| alltime | all time | -133.0% | +36.7% | -140.4% | +59.3% |
CRNX ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | -32.07%(-5.4%) |
| Dec 2024 | -32.02%(-36.2%) | -33.89%(-11.6%) |
| Sep 2024 | - | -38.33%(-9.7%) |
| Jun 2024 | - | -42.43%(-10.0%) |
| Mar 2024 | - | -47.16%(-14.8%) |
| Dec 2023 | -50.16%(-0.8%) | -55.36%(-2.8%) |
| Sep 2023 | - | -56.98%(-1.6%) |
| Jun 2023 | - | -57.89%(+8.1%) |
| Mar 2023 | - | -53.53%(+10.3%) |
| Dec 2022 | -50.57%(+17.7%) | -48.53%(+1.5%) |
| Sep 2022 | - | -47.80%(+7.0%) |
| Jun 2022 | - | -44.67%(-3.6%) |
| Mar 2022 | - | -46.36%(-5.6%) |
| Dec 2021 | -42.98% | -49.13%(-11.0%) |
| Sep 2021 | - | -55.22%(+9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | -50.32%(+12.3%) |
| Mar 2021 | - | -44.81%(+1.3%) |
| Dec 2020 | -43.70%(+1.5%) | -44.24%(+2.1%) |
| Sep 2020 | - | -43.35%(-3.8%) |
| Jun 2020 | - | -45.05%(-0.4%) |
| Mar 2020 | - | -45.23%(+25.8%) |
| Dec 2019 | -43.04%(+154.4%) | -35.94%(+21.8%) |
| Sep 2019 | - | -29.51%(-6.1%) |
| Jun 2019 | - | -31.43%(-10.8%) |
| Mar 2019 | - | -35.25%(-30.4%) |
| Dec 2018 | -16.92%(-127.8%) | -50.67%(-35.7%) |
| Sep 2018 | - | -78.78%(-199.2%) |
| Jun 2018 | - | 79.44%(+15.7%) |
| Mar 2018 | - | 68.66%(+12.6%) |
| Dec 2017 | 60.96%(-37.2%) | 60.96% |
| Dec 2016 | 97.02% | - |
FAQ
- What is Crinetics Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals annual ROE year-on-year change?
- What is Crinetics Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly ROE year-on-year change?
What is Crinetics Pharmaceuticals annual return on equity?
The current annual ROE of CRNX is -32.02%
What is the all time high annual ROE for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual return on equity is 97.02%
What is Crinetics Pharmaceuticals annual ROE year-on-year change?
Over the past year, CRNX annual return on equity has changed by +18.14% (+36.16%)
What is Crinetics Pharmaceuticals quarterly return on equity?
The current quarterly ROE of CRNX is -32.07%
What is the all time high quarterly ROE for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly return on equity is 79.44%
What is Crinetics Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, CRNX quarterly return on equity has changed by +15.09% (+32.00%)